Head & Neck Cancer Clinical Trials

59 clinical trials for Head & Neck Cancer across international registries, including 23 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Feasibility Study on the Implementation of a Supervised, Home-based Adapted Physical Activity Program for Patients With Head and Neck Cancer — RECRUITING · NA
• Improving Dental Care for Patients With Head and Neck Tumors — RECRUITING · NA
• A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients With Head and Neck Cancer. — RECRUITING · PHASE3
• SL-28 for Advanced Solid Tumours — RECRUITING · PHASE1
• Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma — RECRUITING · PHASE2
• REPROton-HN: Prospective Observational Study on Proton Re-irradiation for Locoregional Recurrences of Head and Neck Tumors — RECRUITING
• Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors — RECRUITING · PHASE1
• Specialist Nurse-Led Nursing Management for Patients Undergoing Head and Neck Cancer Surgery — RECRUITING · NA
• Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma — RECRUITING · PHASE3
• FL-261 Imaging for Cancer Diagnosis and Staging — RECRUITING
• Role of the Immune System in Preventing Laryngeal Cancer — RECRUITING
• Impact of Early Response to First-line Anti-PD-1 Monotherapy in Patients With Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma, Assessed by 18F-FDG PET/CT — RECRUITING
• Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy — RECRUITING · NA
• A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1 — RECRUITING · PHASE1
• Nimotuzumab Combined With Toripalimab and Chemotherapy for Locally Advanced Tonsillar Cancer — RECRUITING · PHASE2
• Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer — RECRUITING · PHASE1
• Compare Radiotherapy Plus Nimotuzumab Versus Radiotherapy Alone in Platinum-ineligible Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma — RECRUITING · PHASE3
• Contrast-enhanced Ultrasound for Sentinel Node Detection — RECRUITING · PHASE2
• Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer — RECRUITING · NA
• Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer — RECRUITING · PHASE1
• Human Papillomavirus Association and Genomic Exploration in Head-Neck Squamous Cell Carcinomas — RECRUITING
• Evaluation of Skin Health and QoL in Pts Receiving Anti-PD1/PDL1/CTLA4 or CDK Inhibitors. — RECRUITING
• Newer Therapeutic Targets in Head and Neck Cancers — RECRUITING
• A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors — TERMINATED · PHASE1
• Penpulimab Combined With Chemotherapy for Patients With Locally Advanced Hypopharyngeal Carcinoma — NOT_YET_RECRUITING · PHASE2
• First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients — ACTIVE_NOT_RECRUITING · PHASE2
• Integrated Early-CARE for Head & Neck Cancer. — NOT_YET_RECRUITING · NA
• Vebectotamab Vedotin Combined With Pucotelimab in the Treatment of Locally Advanced Laryngeal Carcinoma — NOT_YET_RECRUITING · PHASE1
• Protein Supplementation for Radiation- Induced Oral Mucositis in Head and Neck Cancer Patients Receiving Radiotherapy — NOT_YET_RECRUITING · NA
• The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors — SUSPENDED · PHASE1
• Longitudinal Oral Health Changes After Head and Neck Radiotherapy — ACTIVE_NOT_RECRUITING
• CApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE) — NOT_YET_RECRUITING · PHASE2
• Intensive Nutritional Counseling in Head-neck Cancer Patients Undergoing Radiotherapy — COMPLETED · NA
• Evaluating Illustrated Vs. Traditional Pamphlets for Enhancing Self-Care in Radiation Therapy Patients — COMPLETED · NA
• Study of Efficacy and Safety of Gabapentin to Reduce the Need for Strong Opioid Use in Head and Neck Cancer Patients. — WITHDRAWN · PHASE3
• Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery — NOT_YET_RECRUITING · PHASE2
• Investigation of Two Swallowing Therapy Models During Radiation Therapy for Head and Neck Cancer — COMPLETED · NA
• Real-World Evidence and Treatment Patterns: Head and Neck Cancer — COMPLETED
• Carotid PET/MRI With DOTATATE in Patients Post Head and Neck Radiation Therapy — COMPLETED · NA
• Pharmacodynamic Effects of Ribavirin in Patients With Tonsil and/or Base of Tongue Squamous Cell Carcinoma — COMPLETED · NA
• Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer — OTHER · NA
• Swallowing Function in Patients With Head and Neck Cancers — COMPLETED · NA
• Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy — COMPLETED · PHASE2
• Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma — TERMINATED · PHASE3
• DRIHNC - Dehydration Reduction in Head & Neck Cancer — COMPLETED · NA
• A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma — TERMINATED · PHASE1
• PCA062 in pCAD-positive Tumors. — COMPLETED · PHASE1
• Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC — COMPLETED · PHASE2
• Brief Intraoperative Electrical Stimulation for Prevention of Shoulder Dysfunction After Oncologic Neck Dissection — COMPLETED · NA

Refine this search